Synthetic Biology

Technologies to create new organisms, including microbes and plants, with valuable capabilities for various applications.

LUX TAKE:

Synthetic biology (synbio) holds disruptive potential as the technology can develop microorganisms for the conversion of sugar and gas feedstocks into products for the traditional petrochemical industry and more. It can unlock low-carbon pathways to existing chemicals and ingredients or create entirely new chemicals and ingredients with unique or improved performance attributes. While synbio’s ...

Lux Take last updated on October 31, 2022
Data last updated on June 01, 2023

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent synthetic biology developments.

News Commentaries

For Earth Day, Lululemon released biobased nylon shirts made from Geno's caprolactam (May 10, 2023)

Ginkgo and Solvay announce partnership to advance synbio footprint (April 11, 2023)

New Lux Content

Technology Landscape: Alternative dairy (June 1, 2023)

Twist Bioscience (June 1, 2023)

Related companies	ATUM, Amyris, Metabolic Explorer, LanzaTech, Global Bioenergies, Ginkgo Bioworks, SyntheZyme, Isobionics, Lygos, Industrial Microbes, Biosyntia, Twist Bioscience, Ecovia Renewables, ChainCraft, Manus Bio, enEvolv, Tandem Repeat, Cubiq Foods, Solugen, Xylome, Sundew, AGvisorPRO, Huue, Colipi Biotech, Algenesis Materials, DAB.bio

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978